Xixiong M. Kang
China P.R
Beijing, 101100, China
Beijing, 101100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A Paradigm to Identify Biomarkers with Tissue Specificity and Disease Causality.
Journal: Omics : a journal of integrative biology
Published: December 17, 2024
A rapid procedure for bacterial identification and antimicrobial susceptibility testing directly from positive blood cultures.
Journal: The Analyst
Published: December 03, 2021
EMT-Related Markers in Serum Exosomes are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas.
Journal: Neuropsychiatric disease and treatment
Published: September 22, 2021
Enhancing the Screening Efficiency of Breast Cancer by Combining Conventional Medical Imaging Examinations With Circulating Tumor Cells.
Journal: Frontiers in oncology
Published: February 16, 2021
Soluble cytotoxic T-lymphocyte-associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma.
Journal: BMC immunology
Published: January 08, 2021
Effect of Bifidobacterium animalis subsp. lactis MN-Gup on constipation and the composition of gut microbiota.
Journal: Beneficial microbes
Published: December 14, 2020
Inhibitory Effect of Tetramerized Single-Chain Variable Fragment of Anti-Cyclic Citrullinated Peptide Antibodies on the Proliferation, Activation, and Secretion of Cytokines of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis In Vitro Co-Culture System.
Journal: Inflammation
Published: August 02, 2020
Rapid Detection of mecA and femA Genes by Loop-Mediated Isothermal Amplification in a Microfluidic System for Discrimination of Different Staphylococcal Species and Prediction of Methicillin Resistance.
Journal: Frontiers in microbiology
Published: January 21, 2020
Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study.
Journal: Scientific reports
Published: November 10, 2019
Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients.
Journal: Journal of medical biochemistry
Published: November 01, 2019
A pilot study of cdc6 as a biomarker for circulating tumor cells in patients with lung cancer.
Journal: Journal of clinical laboratory analysis
Published: October 18, 2019
The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas.
Journal: Frontiers in oncology
Published: October 18, 2019
Last Updated: 09/26/2026